Domača stranSUNPHARMA • NSE
add
Sun Pharmaceutical Industries Ltd
Prejšnji trg. dan.
1683,10 ₹
Dnevni razpon
1669,00 ₹ - 1689,00 ₹
Letni razpon
1455,05 ₹ - 1960,35 ₹
Tržna kapitalizacija
4,03 bil. INR
Povprečni obseg
2,84 mio.
Razm. P/E
35,63
Dividendna donosnost
0,95 %
Primarna borza
NSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (INR) | mar. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 129,59 mrd. | 8,14 % |
Stroški poslovanja | 75,61 mrd. | 20,16 % |
Čisti dohodek | 21,50 mrd. | −19,01 % |
Čista dobičkovnost prihodkov | 16,59 | −25,10 % |
Earnings per share | 10,01 | −13,02 % |
EBITDA | 34,05 mrd. | 9,13 % |
Efektivna davčna stopnja | 33,68 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (INR) | mar. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 249,88 mrd. | 30,89 % |
Skupna sredstva | 921,01 mrd. | 7,77 % |
Skupne obveznosti | 196,15 mrd. | 6,85 % |
Celoten lastniški kapital | 724,86 mrd. | — |
Shares outstanding | 2,39 mrd. | — |
Razmerje P/B | 5,57 | — |
Donosnost sredstev | — | — |
Donosnost kapitala | 9,40 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (INR) | mar. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 21,50 mrd. | −19,01 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Datum ustanovitve
1983
Sedež organizacije
Spletno mesto
Zaposleni
43.000
